A study published in JAMA reports on data showing that Combination ICS-SABA and ICS-Formoterol asthma treatments are more effective than SAMA-only treatment. Details of the study were presented in a session at the American College of Allergy, Asthma and Immunology Annual Scientific Meeting (ACAAI 2024) in Boston.